首页> 外文期刊>journal of chemical crystallography >Solid-state structures and conformational studies of four 1,2,3,4-tetrahydroacridine Alzheimer's disease therapeutics
【24h】

Solid-state structures and conformational studies of four 1,2,3,4-tetrahydroacridine Alzheimer's disease therapeutics

机译:Solid-state structures and conformational studies of four 1,2,3,4-tetrahydroacridine Alzheimer's disease therapeutics

获取原文
       

摘要

The solid-state structures of four 1,2,3,4-tetrahydroacridines tacrine hydrochloride monohydrate (1), 7-methoxytacrine hydrochloride monohydrate (2), velnacrine hydrogenmaleate (3) and suronacrine hydrogenmaleate (4) were determined from single-crystal X-ray diffraction analysis. (1): monoclinic,P21/n, a=8.778(1),b=8.521(1),c=17.603(2)Å, β=101.34(1)°. (2): monoclinic,C2/c, a=12.326(7),b=18.050(9),c=13.822(8)Å, β=113.70(4)°. (3): triclinic,$$Pbar 1$$,a=7.349(2),b=9.417(3),c=12.557(4)Å, α=109.62(2), β=98.12(2), γ=101.18(2)°. (4): monoclinic,P21/n, a=8.513(6),b=18.74(1),c=13.401(6)Å, β=91.21(5)°. FinalRfactors for compounds(1)–(4)are 0.047, 0.057, 0.057, 0.11, respectively. The overall arrangement of the common aminotetrahydroacridine skeleton looks similar in all derivatives. However, whereas enantiomerization of the unsubstituted cyclohexenyl rings occurs in (1) and (2), onlyquasi-axially hydroxyl substituted diastereomers are found for (3) and (4). This is presumably due to the different propensities for hydrogen bonding of axially vs. equatorially disposed hydroxyl groups with the hydrogenmaleate anions. Empirical and semiempirical calculations were performed to examine the conformational behavior of the four compounds, bothin vacuo

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号